RxDoctor Payments Data

Christen Cheuvront

Family · Alliance, OHNPI 1760993455

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $11,300 of the $18,654 with a category attached, or 60.6%. AbbVie accounts for 67.7% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2021 at $8,580 and has fallen 78.0% since, to $1,887 in 2025. Among family clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,654in general payments, 2019–2025

Across 150 payments — averaging $124.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$13K
  • Inspire Medical Systems, Inc.$2K
  • Harmony Biosciences LLC$1K
  • Jazz Pharmaceuticals Inc.$604
  • Noctrix Health, Inc.$571
  • Axsome Therapeutics, Inc.$259
  • plus $2K from 21 others

What the payments were for

  • Speaking & faculty fees$11,30061%
  • Travel & lodging$8064%
  • Food & beverage$6,29734%
  • Education$2501%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,654 in reported general payments places this provider in the 95th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$38,887
Medicare patients
275
Services billed
689

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sodium Oxybate11$194,306
Armodafinil29$4,295
Gabapentin114$1,191
Zolpidem Tartrate ErZolpidem Tartrate25$630
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine17$445
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine12$434
Clonazepam38$302
Ropinirole Hcl38$300
Trazodone Hcl17$285
Fluticasone Propionate35$267
Eszopiclone21$262
Zolpidem Tartrate28$260
Pramipexole DihydrochloridePramipexole Di-Hcl17$242
Zaleplon21$42

Paid to pharmacies, not to this prescriber.

Other family in Alliance

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →